These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31598443)

  • 1. Effects of Length of Vasopressors Infusion on Mortality.
    Kumar V; Srinivas S; Le TH; Barnes M; Kumar S; Redinski J
    Cureus; 2019 Aug; 11(8):e5336. PubMed ID: 31598443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock.
    DeMott JM; Patel G; Lat I
    Ann Pharmacother; 2018 Jan; 52(1):40-47. PubMed ID: 28799416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, Utility, and Safety of Midodrine During Recovery Phase From Septic Shock.
    Whitson MR; Mo E; Nabi T; Healy L; Koenig S; Narasimhan M; Mayo PH
    Chest; 2016 Jun; 149(6):1380-3. PubMed ID: 26953217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
    Zechmeister C; Hurren J; McNorton K
    Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: A retrospective cohort study.
    Delaney A; Finnis M; Bellomo R; Udy A; Jones D; Keijzers G; MacDonald S; Peake S
    Emerg Med Australas; 2020 Apr; 32(2):210-219. PubMed ID: 31599084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to vasopressor initiation and organ failure progression in early septic shock.
    Black LP; Puskarich MA; Smotherman C; Miller T; Fernandez R; Guirgis FW
    J Am Coll Emerg Physicians Open; 2020 Jun; 1(3):222-230. PubMed ID: 33000037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients.
    Kilian S; Surrey A; McCarron W; Mueller K; Wessman BT
    Indian J Crit Care Med; 2022 Jul; 26(7):811-815. PubMed ID: 36864853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Hydrocortisone Continuous Infusion Versus Intermittent Boluses in Resolution of Septic Shock.
    Hoang H; Wang S; Islam S; Hanna A; Axelrad A; Brathwaite C
    P T; 2017 Apr; 42(4):252-255. PubMed ID: 28381918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-complexity measures of heart rate variability and the effect of vasopressor titration: a prospective cohort study of patients with septic shock.
    Brown SM; Sorensen J; Lanspa MJ; Rondina MT; Grissom CK; Shahul S; Mathews VJ
    BMC Infect Dis; 2016 Oct; 16(1):551. PubMed ID: 27724850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of peripheral versus centrally administered vasopressor infusion: A single-centre retrospective observational study.
    Stolz A; Efendy R; Apte Y; Craswell A; Lin F; Ramanan M
    Aust Crit Care; 2022 Sep; 35(5):506-511. PubMed ID: 34600834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of Enteral Nutrition in Mechanically Ventilated Patients With Septic Shock Who Require Vasopressors.
    Merchan C; Altshuler D; Aberle C; Papadopoulos J; Schwartz D
    J Intensive Care Med; 2017 Oct; 32(9):540-546. PubMed ID: 27377392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center.
    Levine M; Curry SC; Padilla-Jones A; Ruha AM
    Ann Emerg Med; 2013 Sep; 62(3):252-8. PubMed ID: 23642908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Vasopressor and Inotrope Use for Health Services Research.
    Fawzy A; Bradford M; Lindenauer PK; Walkey AJ
    Ann Am Thorac Soc; 2016 Mar; 13(3):414-8. PubMed ID: 26653145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting.
    Trocciola SM; Chaer RA; Lin SC; Ryer EJ; De Rubertis B; Morrissey NJ; McKinsey J; Kent KC; Faries PL
    J Vasc Surg; 2006 Apr; 43(4):714-20. PubMed ID: 16616226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Statin Use on Vasopressor Therapy in the Setting of Septic Shock.
    McPheeters CM; Wiedmar JA; Pinkston CM; Weant KA
    Hosp Pharm; 2018 Jun; 53(3):152-156. PubMed ID: 30147135
    [No Abstract]   [Full Text] [Related]  

  • 20. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.